Immutep announces expansion of triple combination therapy in first-line non-small cell lung cancer
Immutep announces expansion of triple combination therapy in first-line non-small cell lung cancer
New South Wales Salah Eddin Al Batran Marc Voigt Institute Of Clinical Cancer Research Immutep Limited Clinical Cancer Research
Source: pharmiweb.com